U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia.
暂无分享,去创建一个
P. Keegan | R. Pazdur | A. Khandelwal | Hong Zhao | M. Rothmann | S. Lemery | S. Casak | Vaishali Jarral | Y. Shen | G. Davis | Mark Rothmann